BioCryst Pharmaceuticals,Inc. (BCRX)

[Femto99]

In US there are approximately 10.000 HAE patients, we already got the FDA ok there.

In Japan there are 2500 patients, we also got there a partner to distribute Bero, Torii Pharmaceuticals. Once we get the approval we will get a 20M$ milestone award. The approval is going to happen within the next 27 days

Finally, in 2021 early Q2 we will get the approval in EU. There are more than 15.000 patients in there.

Remember the cost of Berotralstat is 485k/year.

In the most conservative case, 1000 patients would be equal to 485M$ added to the market cap yearly. Remember it's an oral pill?

https://stocktwits.com/PitBullTrades/message/261502593